Pharmapriser ApS: Financial statements 2018
CVR: 36479868
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
Pharmapriser ApS (CVR 36479868) has filed annual accounts for 2018. In 2018, the company reported revenue of DKK 19,398 and a net result of DKK -77,392 compared with DKK -1,759 the year before. The profit margin was -399%. Equity in the 2018 report amounted to DKK -71,584.
- Revenue
- DKK 19,398
- Gross Profit
- DKK -77,003
- Profit/Loss
- DKK -77,392
- Equity
- DKK -71,584
- Total Assets
- DKK 94,040
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | 19 t. | -77 t. | -77 t. | -72 t. | - |
| 2017 | - | -106 t. | -2 t. | 6 t. | - |
| 2016 | - | -40 t. | -40 t. | 8 t. | - |
| 2015 | - | -3 t. | -3 t. | 47 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
Pharmapriser ApS has published its annual report for 2017. Gross profit came to DKK -105,875, and the net result was DKK -1,759.
As of April 16, 2018, Jacob Frisch is registered as director of Pharmapriser ApS.
As of April 16, 2018, Mads Klixbüll-Axeltoft has stepped down as director of Pharmapriser ApS.
About Pharmapriser ApS
Pharmapriser ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2014. The company is registered under the industry Detailhandel med tøj. The company was previously named MAIN COPENHAGEN ApS. The management consists of Christian Frisch and Oscar Thalund-Jørgensen. The company is owned by JF Consolidated ApS. In 2025, the company reported a gross profit of DKK -6,263 and a net result of DKK -8,073 compared with DKK -1,860 the year before. Equity in the 2025 report amounted to DKK 40,067.